rs892605
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001438036.1(ATP2B2):c.-460+41739C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.771 in 152,052 control chromosomes in the GnomAD database, including 45,635 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.77   (  45635   hom.,  cov: 31) 
Consequence
 ATP2B2
NM_001438036.1 intron
NM_001438036.1 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.115  
Publications
3 publications found 
Genes affected
 ATP2B2  (HGNC:815):  (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008] 
ATP2B2 Gene-Disease associations (from GenCC):
- hearing loss, autosomal dominant 82Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal recessive nonsyndromic hearing loss 12Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.882  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ATP2B2 | NM_001438036.1 | c.-460+41739C>T | intron_variant | Intron 1 of 21 | NP_001424965.1 | |||
| ATP2B2 | XM_005265179.6 | c.-460+25215C>T | intron_variant | Intron 1 of 24 | XP_005265236.1 | |||
| ATP2B2 | XM_006713175.5 | c.-460+41739C>T | intron_variant | Intron 1 of 24 | XP_006713238.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.771  AC: 117136AN: 151934Hom.:  45594  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
117136
AN: 
151934
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.771  AC: 117231AN: 152052Hom.:  45635  Cov.: 31 AF XY:  0.770  AC XY: 57258AN XY: 74320 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
117231
AN: 
152052
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
57258
AN XY: 
74320
show subpopulations 
African (AFR) 
 AF: 
AC: 
36918
AN: 
41496
American (AMR) 
 AF: 
AC: 
11941
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2184
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3798
AN: 
5148
South Asian (SAS) 
 AF: 
AC: 
3529
AN: 
4812
European-Finnish (FIN) 
 AF: 
AC: 
7707
AN: 
10574
Middle Eastern (MID) 
 AF: 
AC: 
176
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
48801
AN: 
67958
Other (OTH) 
 AF: 
AC: 
1586
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1330 
 2660 
 3989 
 5319 
 6649 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 856 
 1712 
 2568 
 3424 
 4280 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2653
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.